Schwarzberg H, Kovács G L, Penke B, Telegdy G
Neuropeptides. 1986 Apr;7(3):247-50. doi: 10.1016/0143-4179(86)90018-1.
Intracerebroventricular (i.c.v.) administration of a test dose of 0.5 microgram D-Met2-Pro5-enkephalinamide (ENK) resulted in analgesia. Acute tolerance developed if a tolerance-inducing high dose of 5 micrograms ENK was administered i.c.v. prior to the test dose. Tolerance appeared as a reduction of the analgesic effect of the test dose. Subcutaneous (s.c.) injection of oxytocin (OXT) inhibited the development of tolerance. It is suggested that OXT is able to modify the development of tolerance to enkephalins, which are ligands of delta-opiate rather than mu-opiate receptors.
脑室内(i.c.v.)注射0.5微克的测试剂量D-蛋氨酸2-脯氨酸5-脑啡肽酰胺(ENK)可产生镇痛作用。如果在测试剂量之前脑室内注射5微克诱导耐受性的高剂量ENK,则会产生急性耐受性。耐受性表现为测试剂量镇痛作用的降低。皮下(s.c.)注射催产素(OXT)可抑制耐受性的产生。提示OXT能够改变对脑啡肽耐受性的产生,脑啡肽是δ阿片受体而非μ阿片受体的配体。